David Colleran's Net Worth
$11.5 Million
Who is David Colleran?
David Colleran has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include INSULET CORP, and Anika Therapeutics, Inc..
SEC CIK
David Colleran's CIK is 0001646558
Past Insider Trading and Trends
2019 was David Colleran's most active year for acquiring shares with 7 total transactions. David Colleran's most active month to acquire stocks was the month of February. 2019 was David Colleran's most active year for disposing of shares, totalling 14 transactions. David Colleran's most active month to dispose stocks was the month of February. 2019 saw David Colleran paying a total of $1,315,812.92 for 40,030 shares, this is the most they've acquired in one year. In 2019 David Colleran cashed out on 84,072 shares for a total of $3,975,511.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INSULET CORP (PODD) Snapshot price: $214.75
SVP, Secretary and GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$62.94 | -$472,614.45 | 30.43K |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
$65.10 | -$1,239,815.04 | 30.43K |
Mar 1
| |||
Form 4
| -10.97% | -3.75K |
$87.60 | -$328,324.80 | 30.43K |
Feb 22 - Feb 24
| |||
Form 4
| -0.77% | -264.00 |
$84.83 | -$22,395.12 | 34.18K |
Feb 14
| |||
Form 4
|
—
|
0
|
$54.99 | -$351,677.64 | 34.13K |
Scheduled
|
Feb 5
| ||
Form 4
|
—
|
0
|
$54.63 | -$244,871.24 | 34.13K |
Scheduled
|
Jan 31
| ||
Form 4
|
—
|
0
|
$61.01 | -$237,182.23 | 34.04K |
Scheduled
|
Nov 14
| ||
Form 4
| -8.60% | -3.21K |
$85.70 | -$274,668.50 | 34.04K |
Jun 29
| |||
Form 4
| -11.77% | -4.96K |
$86.24 | -$427,405.44 | 37.14K |
Scheduled
|
May 15
| ||
Form 4
| -5.46% | -2.43K |
$75.55 | -$183,586.50 | 42.09K |
Feb 24
| |||
Form 4
| -1.04% | -470.00 |
$80.46 | -$37,816.20 | 44.52K |
Feb 22
| |||
Form 4
| +48.26% | 14.65K |
—
|
—
| 44.99K |
Feb 13 - Feb 14
| |||
Form 4
| +16.57% | 4.33K |
—
|
—
| 30.44K |
Feb 22
| |||
Form 4
| -8.25% | -2.35K |
$29.71 | -$69,729.37 | 26.11K |
Jun 29
| |||
Form 4
| +31.60% | 6.83K |
—
|
—
| 28.46K |
Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anika Therapeutics, Inc. (ANIK) Snapshot price: $24.56
EVP, General Counsel, Corp Sec
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +56.21% | 11.87K |
$25.59 | -$126,305.62 | 32.99K |
Mar 11
| |||
Form 4
| +36.39% | 5.41K |
$26.10 | -$58,725.00 | 20.29K |
Mar 10
| |||
Form 4
| +21.20% | 2.6K |
$26.91 | -$29,089.71 | 14.88K |
Mar 9
| |||
Form 4
| +16.81% | 1.77K |
$31.59 | -$23,187.06 | 12.27K |
Mar 4
| |||
Form 4
| +17.93% | 1.5K |
$21.37 | $32,055.00 | 9.87K |
May 11
| |||
Form 4
| +21.84% | 1.5K |
$26.65 | $39,978.00 | 8.37K |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +60.97% | 2.6K |
$26.22 | -$28,343.82 | 6.87K |
Mar 9
| |||
Form 4
| +70.64% | 1.77K |
$31.06 | -$22,798.04 | 4.27K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||